⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AARD News
Aardvark Therapeutics, Inc. Common Stock
Pomerantz LLP Has Filed Class Action Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
Class Action Lawsuit Filed Against Aardvark Therapeutics, Inc. (AARD) - Recover Losses - Contact Levi & Korsinsky Before October 13, 2026
accessnewswire.com
AARD
October 13, 2026 Deadline Approaching: Join Class Action Against Aardvark Therapeutics, Inc. (AARD) - Contact Levi & Korsinsky
accessnewswire.com
AARD
AARD ALERT: Securities Fraud Class Action Launched Against Aardvark Therapeutics, Inc. - October 13, 2026 Deadline
accessnewswire.com
AARD
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AARD
accessnewswire.com
AARD
INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Aardvark Therapeutics, Inc. (AARD) to Contact Law Firm
prnewswire.com
AARD
Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadline
prnewswire.com
AARD
AARD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
AARD
AARDVARK THERAPEUTICS, INC. INVESTORS WITH LOSSES HAVE UNTIL OCTOBER 13, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
globenewswire.com
AARD
Faruqi & Faruqi, LLP Urges Aardvark Therapeutics (AARD) Investors to Seek Counsel Before October 13, 2026 Lead Plaintiff Deadline in the Securities Class Action Ready to Announce with Confidence?
newsfilecorp.com
AARD